Search

everythinglearnresearchcommunity

for

Search:↓

Combined oral contraceptives improve skin, hormone levels, and quality of life in women with PCOS.

Platelet-rich plasma therapy shows promise for hair regrowth in alopecia patients.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

The supplement with Myo-inositol and D-chiro-inositol improves metabolic symptoms in PCOS, especially when combined with metformin.

N-acetylcysteine was more effective and had fewer side effects than metformin for improving insulin resistance in women with PCOS.

Cernitin™, a pollen extract, was found to significantly reduce pain and inflammation in rats with chronic prostatitis, suggesting it could be a useful alternative to certain anti-inflammatory drugs.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Hypothyroidism may worsen metabolic problems like insulin resistance and obesity in women with PCOS.

The document suggests new ways to assess and diagnose hyperandrogenism to improve accuracy.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Steroid hormones can help treat aging issues and improve health in elderly people.

Isoflavone may help manage PCOS symptoms, but its effectiveness is uncertain.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

African American women have a higher risk of preterm delivery than Caucasian women, and inflammatory stimuli affect gene expression in cells related to PCOS, showing a heightened inflammatory state in women with PCOS.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

Licorice extract helps hair growth and may treat hair loss.

2-deoxy-D-ribose gel may help regrow hair in cases of hair loss.

Low vitamin D levels are linked to increased risk of male pattern baldness.

PCOS has many symptoms, with high androgen levels being the most common.

Different treatments for PCOS should be tailored to the individual, including lifestyle changes and various medications.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

Finasteride affects the male rat brain by reducing certain protein activation, but these effects may reverse after stopping the drug.

New compounds may help treat prostate cancer by reducing cell growth.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Polycystic Ovarian Syndrome is common in overweight urban college girls and may increase the risk of heart and metabolic problems.

A 13-year-old with 46 XY DSD had ambiguous genitalia due to incomplete masculinization.